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I congratulate the successful perioperative management done for the patient
with a left ventricular assist device (LVAD), whose medications were adjusted
considering remotely monitored pulmonary artery pressure that CardioMEMS
supplied [1]. Our team recently demonstrated that optimized haemodynamics
was associated with reduced haemocompatibility-related adverse events
including heart failure recurrence [2], and efforts to optimize haemodynamics
by adjusting LVAD speed and medications are recommended for successful
LVAD therapy. One of the major limitations of this strategy is the invasiveness
of right heart catheterization to measure haemodynamics, particularly in
LVAD patients under anticoagulation and antiplatelet therapy. CardioMEMS, a
non-invasive procedure, might overcome such limitations and enable us to re-
peat haemodynamic assessments.
However, we should pay attention to the ‘decoupling’ between diastolic pul-
monary artery pressure and pulmonary capillary wedge pressure (PCWP).
Almost half of the clinically stable LVAD patients have such decoupling [3].
Many LVAD patients may have ‘normal’ PCWP despite ‘abnormally’ elevated
pulmonary artery pressure. In other words, the pulmonary artery pressure
may not always be an alternative to PCWP in LVAD patients. CardioMEMS-
guided medication adjustment, blinded to the actual level of PCWP, may carry
a risk of inflow cannula sucking due to excessive uptitration of diuretics.
Nevertheless, I once again congratulate them on their successful management
using CardioMEMS. Such a strategy would pave the way for the concept of a
‘smart pump’, which adjusts LVAD speed automatically using monitored
haemodynamic parameters.
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We thank Imamura for his comments on our recently published case report
[1, 2]. We demonstrated that the use of haemodynamic feedback, provided by
the CardioMEMS device, during the optimization phase prior to left ventricu-
lar assist device (LVAD) implantation, leads to further haemodynamic opti-
mization [2]. This strategy allows for daily haemodynamic monitoring,
provides direct feedback on medical therapy and is less invasive when com-
pared with continuous or repeated haemodynamic Swan–Ganz measure-
ments. Furthermore, this technique carries minimal risk of bleeding or
infection complications, which are known limitations of central lines needed
for continuous monitoring using Swan–Ganz measurements [3].
We hypothesize that the CardioMEMS device is a very useful tool for post-
operative monitoring and also the management of LVAD patients, as it pro-
vides daily information on the pulmonary artery pressure in a remote and
non-invasive way. However, it has been shown that decoupling of pulmonary
artery and pulmonary capillary wedge pressures occurs in LVAD patients [4].
We agree with Imamura [1] that this decoupling between pressures might limit
the use of this remote monitoring strategy in LVAD patients, especially when
clinicians use only pulmonary artery pressure for patient management and
medication titration. This could lead to excessive uptitration of diuretics, lead-
ing to dehydration of the LVAD patient, potentially resulting in suction events
or other related adverse events.
However, at this moment, no information in the literature is available
describing the effect of decoupling on this monitoring strategy. Currently, we
are investigating the safety and utility of the combination of LVAD therapy
and remote haemodynamic monitoring using the CardioMEMS for the first
time [5]. Our results will provide more insight into the effects of remote moni-
toring of LVAD patients using the CardioMEMS device.
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We read with great interest, the case report from Wang et al. [1]. They
reported for the first time, a rare but lethal surgical complication after a cryo-
maze ablation was performed by sternotomy, during an aortic valve
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